IP Library Granted Patent US 8,460,927
Granted Patent B2
US 8,460,927 · App. 13/280,779 · Granted Jun 11, 2013

B7-H1 antibodies and method of use

Inventor: Lieping Chen (Hamden, CT)
Assignee: Mayo Foundation for Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,927
App. No.
13/280,779
Granted
Jun 11, 2013
Kind
B2
Abstract

The invention provides novel polypeptides useful for co-stimulating T cells, isolated nucleic acid molecules encoding them, vectors containing the nucleic acid molecules, and cells containing the vectors. Also included are methods of making and using these co-stimulatory polypeptides.

Claims (15)

1. A method for inhibiting a co-stimulatory effect of B7-H1 on T-cells, comprising:

contacting said B7-H1 with an isolated antibody that binds specifically to a B7-H1 polypeptide which comprises

(a) amino acids having the sequence set forth in SEQ ID NO:1; or

(b) amino acids that are encoded by a polynucleotide comprising nucleotides having the sequence set forth in SEQ ID NO:2,

wherein the contacting comprises culturing the antibody with the T-cell in vitro, to thereby inhibit a co-stimulatory effect of B7-H1 on T-cells.

2. An isolated antibody that binds specifically to a B7-H1 polypeptide which comprises

(a) amino acids having the sequence set forth in SEQ ID NO:3; or

(b) amino acids that are encoded by a polynucleotide comprising nucleotides having the sequence set forth in SEQ ID NO:4.

3. An antibody fragment that binds specifically to a B7-H1 polypeptide which comprises

(a) amino acids having the sequence set forth in SEQ ID NO:3; or

(b) amino acids that are encoded by a polynucleotide comprising nucleotides having the sequence set forth in SEQ ID NO:4.

4. An isolated antibody according to claim 2 that binds specifically to the polypeptide comprising amino acids having the sequence set forth in SEQ ID NO:16.

5. An isolated antibody fragment according to claim 3 that binds specifically to the polypeptide comprising amino acids having the sequence set forth in SEQ ID NO:16.

6. A method for inhibiting a co-stimulatory effect of B7-H1 on T-cells, comprising:

contacting said B7-H1 with an isolated antibody or an antigen binding fragment thereof which binds specifically to a soluble B7-H1 polypeptide which is not membrane-bound, wherein said soluble B7-H1 polypeptide comprises amino acid domain(s) having the sequence(s) shown in FIG. 2A (SEQ ID NO:1) such that the polypeptide is soluble, to thereby inhibit a co-stimulatory effect of B7-H1 on T-cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2016
From: CHEN, LIEPING
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 039458/0425 →
CONFIRMATORY LICENSE Recorded Nov 17, 2011
From: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027248/0612 →
Continuity (5)
Continuation 12421310 · Apr 9, 2009
Continuation 12347492 · Dec 31, 2008
Continuation 09649108 · Aug 28, 2000
Continuation In Part 09451291 · Nov 30, 1999
Related Publication 20120064626A1 · Mar 15, 2012